Meta Pixel

News and Announcements

Viralytics Ltd (ASX:VLA) – CEO Interview

  • Published December 14, 2012 10:18AM UTC
  • Publisher Wholesale Investor
  • Categories Executive Interviews

Viralytics is an Australian Stock Exchange listed company developing a portfolio of Oncolytic viruses that have the potential not only to provide a more effective treatment of a range of cancers, but also a substantial improvement in patients quality of life. Focused on developing oncolytic virotherapy for the treatment of a wide range of cancers Viralytics’ headquarters are in Sydney, Australia and research and operations are in Newcastle, Australia.


Capital Insights
The Great Life Science Reset: Why the “Sick Care” Model is Failing

The data reveals a significant transition: the end of the traditional sick care model and the rise of a proactive healthcare ecosystem. Learn how smart money is utilising AI to cut drug discovery times in half, transform diagnostics to detect complex diseases in days, and create efficiencies to scale the healthcare system without a proportional increase in costs.

Capital Insights
Australia’s A$4 Trillion Generational Pivot

Australia’s wealth management landscape is undergoing a dramatic transformation. For decades, family offices operated quietly during the “Great Moderation”, an era characterised by low volatility, cheap capital, and global economic synchronisation. Today, that stability has given way to fiscal uncertainty, geopolitical tensions, and intensifying regulatory scrutiny. Yet amid this global turbulence, Australia has emerged as […]

Join over 45,000+ sophisticated investors

Join Now